FORWARD PHARMA A/S's ticker is FWP and the CUSIP is 34986J105. A total of 24 filers reported holding FORWARD PHARMA A/S in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $733,000 | -53.2% | 34,000 | -67.4% | 0.04% | -56.0% |
| Q4 2016 | $1,565,000 | -24.8% | 104,273 | +5.3% | 0.09% | +16.7% |
| Q3 2016 | $2,080,000 | +12.1% | 99,053 | -3.0% | 0.08% | -19.6% |
| Q2 2016 | $1,856,000 | +42.2% | 102,135 | +33.0% | 0.10% | +49.2% |
| Q1 2016 | $1,305,000 | -1.9% | 76,785 | +9.7% | 0.06% | -11.0% |
| Q4 2015 | $1,330,000 | -19.3% | 70,000 | 0.0% | 0.07% | +7.4% |
| Q3 2015 | $1,649,000 | +23.6% | 70,000 | +99.7% | 0.07% | +38.8% |
| Q2 2015 | $1,334,000 | -47.7% | 35,050 | -61.1% | 0.05% | -53.8% |
| Q1 2015 | $2,550,000 | – | 90,060 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 100,000 | $2,356,000 | 16.27% |
| BVF INC/IL | 1,016,324 | $23,945,000 | 4.84% |
| Baupost Group | 5,367,300 | $126,454,000 | 2.11% |
| Cormorant Asset Management, LP | 335,068 | $7,894,000 | 1.26% |
| EcoR1 Capital, LLC | 101,995 | $2,403,000 | 1.09% |
| HELLMAN JORDAN MANAGEMENT CO INC /MA/ | 157,397 | $3,708,000 | 0.92% |
| Assured Investment Management LLC | 1,102,924 | $25,985,000 | 0.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 135,000 | $3,181,000 | 0.41% |
| CLOUGH CAPITAL PARTNERS L P | 260,300 | $6,133,000 | 0.26% |
| Orbimed Advisors | 960,600 | $22,632,000 | 0.23% |